- Tytuł:
-
The influence of
obesity -related factors in the etiology of renal cell carcinoma-A mendelian randomization study. - Autorzy:
-
Johansson M; International Agency for Research on Cancer (IARC), Lyon, France.
Carreras-Torres R; International Agency for Research on Cancer (IARC), Lyon, France.
Scelo G; International Agency for Research on Cancer (IARC), Lyon, France.
Purdue MP; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Mariosa D; International Agency for Research on Cancer (IARC), Lyon, France.
Muller DC; Imperial College, London, United Kingdom.
Timpson NJ; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
Haycock PC; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.
Brown KM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Wang Z; St. Jude Children's Research Hospital, Memphis, Tennessee, United States of America.
Ye Y; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Hofmann JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Foll M; International Agency for Research on Cancer (IARC), Lyon, France.
Gaborieau V; International Agency for Research on Cancer (IARC), Lyon, France.
Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Colli LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Li P; International Agency for Research on Cancer (IARC), Lyon, France.; Max Planck Institute for Demographic Research, Rostock, Germany.
Garnier JG; Centre National de Genotypage, Institut de Genomique, Centre de l'Energie Atomique et aux Energies Alternatives, Evry, France.; Fondation Jean Dausset - Centre d'Etude du Polymorphisme Humain, Paris, France.
Blanche H; Fondation Jean Dausset - Centre d'Etude du Polymorphisme Humain, Paris, France.
Boland A; Centre National de Genotypage, Institut de Genomique, Centre de l'Energie Atomique et aux Energies Alternatives, Evry, France.
Burdette L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Prokhortchouk E; Federal Research Centre 'Fundamentals of Biotechnology' of the Russian Academy of Sciences, Moscow, Russian Federation.
Skryabin KG; Federal Research Centre 'Fundamentals of Biotechnology' of the Russian Academy of Sciences, Moscow, Russian Federation.; Kurchatov Scientific Center, Moscow, Russian Federation.
Yeager M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Radojevic-Skodric S; Institute of Pathology, Medical School of Belgrade, Belgrade, Serbia.; Clinic of Urology, Clinical Center of Serbia, Belgrade, Serbia.
Ognjanovic S; Mayo Clinic Graduate School of Biomedical Sciences, Rochester, Minnesota, United States of America.; International Organization for Cancer Prevention and Research (IOCPR), Belgrade, Serbia.
Foretova L; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Holcatova I; Institute of Public Health and Preventive Medicine, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
Janout V; Department of Preventive Medicine, Faculty of Medicine, Palacky University, Olomouc, Czech Republic.
Mates D; National Institute of Public Health, Bucharest, Romania.
Mukeriya A; Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
Rascu S; Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.
Zaridze D; Russian N.N. Blokhin Cancer Research Centre, Moscow, Russian Federation.
Bencko V; Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Fabianova E; Regional Authority of Public Health in Banska Bystrica, Banska Bystrica, Slovakia.
Jinga V; Carol Davila University of Medicine and Pharmacy, Th. Burghele Hospital, Bucharest, Romania.
Lissowska J; The M Sklodowska-Curie Cancer Center and Institute of Oncology, Warsaw, Poland.
Lubinski J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland.
Navratilova M; Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.
Rudnai P; National Public Health Center, National Directorate of Environmental Health, Budapest, Hungary.
Benhamou S; INSERM U946, Paris, France.; CNRS UMR8200, Institute Gustave Roussy, Villejuif, France.
Cancel-Tassin G; CeRePP, Paris, France.; UPMC Univ Paris 06, GRC n°5, Institut Universitaire de Cancérologie, Paris, France.
Cussenot O; CeRePP, Paris, France.; UPMC Univ Paris 06, GRC n°5, Institut Universitaire de Cancérologie, Paris, France.; AP-HP, Department of Urology, Hopitaux Universitaires Est Parisien Tenon, Paris, France.
Weiderpass E; Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway.; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland.; Department of Community Medicine, University of Tromsø, The Arctic University of Norway, Tromsø, Norway.
Ljungberg B; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
Tumkur Sitaram R; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.
Häggström C; Department of Biobank Research, Umeå University, Umeå, Sweden.; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Bruinsma F; Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia.
Jordan SJ; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; School of Public Health, The University of Queensland, Brisbane, Australia.
Severi G; 'Health across generations' team, CESP Inserm, Facultés de Médicine Université Paris-Sud, UVSQ, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Human Genetics Foundation (HuGeF), Torino, Italy.
Winship I; Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia.
Hveem K; K. G. Jebsen Center for Genetic Epidemiology, Department of Public Health, Norwegian University of Science and Technology, Trondheim, Norway.
Vatten LJ; Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Fletcher T; London School of Hygiene and Tropical Medicine, University of London, London, United Kingdom.
Larsson SC; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Wolk A; Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Banks RE; Leeds Institute of Cancer and Pathology, University of Leeds, St James's University Hospital, Leeds, United Kingdom.
Selby PJ; National Institute for Health Research Diagnostic Evidence Cooperative, Division of Surgery, Imperial College London, St Mary's Hospital, London, United Kingdom.
Easton DF; Department of Oncology, University of Cambridge, Cambridge, United Kingdom.; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Andreotti G; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Beane Freeman LE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Koutros S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Männistö S; National Institute for Health and Welfare, Helsinki, Finland.
Weinstein S; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Clark PE; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States of America.
Edwards TL; Department of Medicine, Division of Epidemiology, Vanderbilt-Ingram Cancer Center, Vanderbilt Genetics Institute, Nashville, Tennessee, United States of America.
Lipworth L; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States of America.
Gapstur SM; American Cancer Society, Atlanta, Georgia, United States of America.
Stevens VL; American Cancer Society, Atlanta, Georgia, United States of America.
Carol H; Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Freedman ML; Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Pomerantz MM; Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Cho E; Brown University, Providence, Rhode Island, United States of America.
Wilson KM; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
Gaziano JM; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.
Sesso HD; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Freedman ND; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Parker AS; Department of Health Sciences Research, Mayo Clinic, Jacksonville, Florida, United States of America.
Eckel-Passow JE; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America.
Huang WY; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Kahnoski RJ; Division of Urology, Spectrum Health, Grand Rapids, Michigan, United States of America.
Lane BR; Division of Urology, Spectrum Health, Grand Rapids, Michigan, United States of America.; College of Human Medicine, Michigan State University, Grand Rapids, Michigan, United States of America.
Noyes SL; Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, Michigan, United States of America.; Spectrum Health, Grand Rapids, Michigan, United States of America.
Petillo D; Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, Michigan, United States of America.; Diagnostics Program at Ferris State University, Grand Rapids, Michigan, United States of America.
Teh BT; Van Andel Research Institute, Center for Cancer Genomics and Quantitative Biology, Grand Rapids, Michigan, United States of America.; Program in Cancer and Stem Cell Biology, Duke-National, University of Singapore Medical School, Singapore, Singapore.; Institute of Molecular and Cell Biology, A*STAR, Singapore, Singapore.; Laboratory of Cancer Epigenome, Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Peters U; Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
White E; Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Anderson GL; WHI Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Johnson L; Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Luo J; Department of Epidemiology and Biostatistics, School of Public Health Indiana University Bloomington, Bloomington, Indiana, United States of America.
Buring J; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.
Lee IM; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, United States of America.Chow WH; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Moore LE; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Eisen T; University of Cambridge, Cambridge, United Kingdom.
Henrion M; The Institute of Cancer Research, London, United Kingdom.; Dept. of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, United States of America.
Larkin J; Royal Marsden NHS Foundation Trust, London, United Kingdom.
Barman P; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America.
Leibovich BC; Department of Urology, Mayo Clinic, Rochester, Minnesota, United States of America.
Choueiri TK; Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Lathrop GM; McGill University and Genome Quebec Innovation Centre, Montreal, Quebec, Canada.
Deleuze JF; Centre National de Genotypage, Institut de Genomique, Centre de l'Energie Atomique et aux Energies Alternatives, Evry, France.; Fondation Jean Dausset - Centre d'Etude du Polymorphisme Humain, Paris, France.
Gunter M; International Agency for Research on Cancer (IARC), Lyon, France.
McKay JD; International Agency for Research on Cancer (IARC), Lyon, France.
Wu X; Department of Epidemiology, Division of Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Houlston RS; The Institute of Cancer Research, London, United Kingdom.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department Health and Human Services, Bethesda, Maryland, United States of America.
Relton C; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.; School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Richards JB; Departments of Medicine, Human Genetics, Epidemiology and Biostatistics, Jewish General Hospital, McGill University, Montreal, Quebec, Canada.
Martin RM; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.; School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.; University Hospitals Bristol NHS Foundation Trust National Institute for Health Research Bristol Nutrition Biomedical Research Unit, University of Bristol, Bristol, United Kingdom.
Davey Smith G; MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.; School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom.
Brennan P; International Agency for Research on Cancer (IARC), Lyon, France. - Pokaż więcej
- Źródło:
- PLoS medicine [PLoS Med] 2019 Jan 03; Vol. 16 (1), pp. e1002724. Date of Electronic Publication: 2019 Jan 03 (Print Publication: 2019).
- Typ publikacji:
- Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Carcinoma, Renal Cell/*etiology
Kidney Neoplasms/*etiologyObesity /*complications
Blood Glucose/analysis ; Blood Pressure ; Body Mass Index ; Carcinoma, Renal Cell/genetics ; Diabetes Mellitus, Type 2/complications ; Female ; Genetic Markers ; Genome-Wide Association Study ; Humans ; Insulin/blood ; Kidney Neoplasms/genetics ; Lipids/blood ; Male ; Mendelian Randomization Analysis ;Obesity /genetics ; Risk Factors
Czasopismo naukowe